← EU Feed

Global Synthetic Bone Graft Substitutes Market Size/Share Worth USD 2.7 Billion by 2035 at a 6.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Source Summary

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Synthetic Bone Graft Substitutes Market size & share revenue was valued at approximately USD 1.4 Billion in 2025 and is expected to reach USD 1.5 Billion in 2026 and is expected to reach around USD 2.7 Billion by 2035, at a CAGR of 6.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Medtronic plc, DePuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings Inc., Stryker Corporation, Baxter International Inc., Arthrex Inc., Smith & Nephew plc, NuVasive Inc., RTI Surgical Holdings Inc., Integra LifeSciences Holdings Corporation, BioHorizons Implant Systems Inc., Geistlich Pharma AG, BioMimetic Therapeutics (or similar emerging biologics), AlloSource, Cortex (Zimmer/BioHorizons partner or subsidiary) [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Synthetic Bone Graft Substitutes Market size & share revenue was valued at approximately USD 1.4 Billion in 2025 and is expected to reach USD 1.5 Billion in 2026 and is expected to reach around USD 2.7 Billion by 2035, at a CAGR of 6.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Medtronic plc, DePuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings Inc., Stryker Corporation, Baxter International Inc., Arthrex Inc., Smith & Nephew plc, NuVasive Inc., RTI Surgical Holdings Inc., Integra LifeSciences Holdings Corporation, BioHorizons Implant Systems Inc., Geistlich Pharma AG, BioMimetic Therapeutics (or similar emerging biologics), AlloSource, Cortex (Zimmer/BioHorizons partner or subsidiary)

Advertisement
Read Original Article